KY HB 156
died on adjournmentAN ACT relating to intranasal epinephrine.
Kentucky · 2026 Regular Session · lower
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did KY HB 156 pass?
No. KY HB 156 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-01-14): to Health Services (H)
What is KY HB 156 about?
Amend KRS 158.832 to include intranasal epinephrine to list of medications used to treat anaphylaxis; amend KRS 158.836 to include intranasal epinephrine as permissible for schools to keep.
Who sponsors KY HB 156?
G. Brown Jr., A. Moore, A. Camuel are the primary sponsors of KY HB 156.
Description
Amend KRS 158.832 to include intranasal epinephrine to list of medications used to treat anaphylaxis; amend KRS 158.836 to include intranasal epinephrine as permissible for schools to keep.
- Introduced
- 2026-01-07
- Latest action
- 2026-01-14 — to Health Services (H)
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- G. Brown Jr.primary
- A. Mooreprimary
- A. Camuelprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-01-14
to Health Services (H)
referral-committee
2026-01-07
to Committee on Committees (H)
referral-committee
2026-01-07
introduced in House
introduction
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_api_sync, retrieved 2026-08-21T21:05:44.493618Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=KY&identifier=HB 156. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.